Shortened dual antiplatelet therapy after CABG: important evidence but unanswered questions remain

Agreement: I Agree Body: Dear Editor, I read with great interest the study conducted on three months versus 12 months of dual antiplatelet therapy (DAPT) using ticagrelor and aspirin after saphenous vein grafting during coronary artery bypass surgery (CABG). We compliment the authors for conducting a large scale, double blind, multicenter non-inferiority study on an important clinical topic. The observation that three-month DAPT is as effective as 12-month DAPT in terms of graft occlusion but re